Morphological alterations induced by doxorubicin in B16 melanoma cells

Cancer Lett. 1990 Jun 15;51(3):209-12. doi: 10.1016/0304-3835(90)90104-6.

Abstract

In B16 melanoma, cells morphologically different can be distinguished. In order to establish possible correlations between cell morphology and drug-response, the cytotoxic response to doxorubicin was analyzed. The two subpopulations, represented by two types of colonies, showed a different degree of sensitivity to doxorubicin. Moreover, following treatment, colonies strongly altered in their morphology were found, suggesting a differentiating activity of doxorubicin (dendritic prolongations, increase of intracellular melanin, block of cell proliferation). These results suggest that doxorubicin, besides having a different cytotoxic effect on the two cell subpopulations, induces in this cell line morphological alterations consistent with a differentiation process.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cell Division / drug effects
  • Cell Survival / drug effects
  • Dose-Response Relationship, Drug
  • Doxorubicin / pharmacology*
  • Melanins / analysis
  • Melanoma / pathology*
  • Melanoma / ultrastructure
  • Mice
  • Time Factors
  • Tumor Cells, Cultured / drug effects

Substances

  • Melanins
  • Doxorubicin